ViewsML
ViewsML Technologies provides AI-driven virtual diagnostics that let researchers replace traditional immunohistochemistry with computational biomarkers to speed spatial biology and translational research. The company virtualizes IHC by applying deep learning to histopathology and tissue imaging to generate virtual biomarkers and richer datasets while reducing wet-lab time and costs. Its offering is a B2B SaaS-like research tool for translational research labs, pharmaceutical developers, and precision medicine teams. Core technologies include convolutional neural networks for image analysis and integrations with spatial biology workflows and research imaging pipelines. ViewsML targets the translational research and precision medicine market by improving diagnostic throughput, data depth, and budget efficiency for lab-based customers.
ViewsML
ViewsML Technologies provides AI-driven virtual diagnostics that let researchers replace traditional immunohistochemistry with computational biomarkers to speed spatial biology and translational research. The company virtualizes IHC by applying deep learning to histopathology and tissue imaging to generate virtual biomarkers and richer datasets while reducing wet-lab time and costs. Its offering is a B2B SaaS-like research tool for translational research labs, pharmaceutical developers, and precision medicine teams. Core technologies include convolutional neural networks for image analysis and integrations with spatial biology workflows and research imaging pipelines. ViewsML targets the translational research and precision medicine market by improving diagnostic throughput, data depth, and budget efficiency for lab-based customers.